Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,850,166
+$1,371,260 QoQ
Shares Held
122,031
+0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.74%
of 13F equity value
Holder Rank
#196
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Round Hill Asset Management holds $42,939,237 across 7 Drug Manufacturers - General names. NVO ranks #3 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
37,380 | $13,536,045 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,350 | $9,168,475 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
122,031 | $5,850,166 | |
| 4 | PFE |
Pfizer Inc
|
242,134 | $5,830,586 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,646 | $4,128,242 | |
| 6 | ABBV |
AbbVie Inc.
|
15,475 | $3,894,129 | |
| 7 | NVS |
Novartis AG
|
3,392 | $531,594 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,850,166 | 122,031 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,478,906 | 121,875 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,968,940 | 97,660 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,201,980 | 75,725 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,936,831 | 57,039 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,001,757 | 57,629 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,980,471 | 57,899 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,894,033 | 57,899 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,264,503 | 57,899 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,588,953 | 59,104 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,382,761 | 61,699 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,004,222 | 66,024 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,852,905 | 36,167 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,962,498 | 37,467 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,740,716 | 42,417 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,583,478 | 46,005 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,126,337 | 46,005 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,351,610 | 48,191 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,474,000 | 48,875 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,706,890 | 49,025 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,134,049 | 49,350 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,327,177 | 49,350 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,451,637 | 49,415 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,440,603 | 49,555 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,244,861 | 49,555 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,992,241 | 49,705 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||